Latest International Development News

Page 1 of 7
Bayan Mining and Minerals has completed nine University of Queensland ion-exchange runs, recording an 11.2-fold peak increase in yttrium purity. The result strengthens the technical case for its licensed processing technology, but commercial feeds, recovery, costs and pilot performance remain untested.
Maxwell Dee
Maxwell Dee
12 Nov 2026
Pacific Lime and Cement has secured firm commitments for a A$50 million placement while advancing a proposed US$15 million convertible note with the United States International Development Finance Corporation. The funding is aimed at moving its Papua New Guinea lime, cement, port and industrial precinct projects towards construction and commercialisation.
Victor Sage
Victor Sage
9 Nov 2026
A US$1.536 million US Government grant will fund a two-year campaign to attract investment, commercial partners and engineering expertise to PhosCo’s Gasaat phosphate project in Tunisia. The opportunity is significant, but the money goes to adviser CrossBoundary and does not guarantee funding for PhosCo.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026
Adisyn has identified graphene at all 12 sampled locations on a full 200mm wafer, moving its low-temperature deposition platform beyond 1cm² laboratory coupons. The ASX-listed technology company ended September with A$14.4 million in cash and no debt, but commercial qualification remains ahead.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Syrah Resources is set to receive a further US$15 million from the US International Development Finance Corporation before the end of October, providing working and sustaining capital for its Balama graphite operation. The funding comes with a temporary waiver of existing loan defaults, new warrants and no guarantee of further disbursements.
Victor Sage
Victor Sage
26 Oct 2026
Beamtree Holdings has paired 10% recurring revenue growth with a $13.1 million non-cash impairment and a year-end debt covenant breach. The ASX-listed healthcare software company is betting that a tighter product portfolio, new leadership and FY27 execution can stabilise the balance sheet.
Victor Sage
Victor Sage
23 Oct 2026
Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.
Victor Sage
Victor Sage
23 Oct 2026
Aura Energy’s Tiris uranium project has emerged from its bankable feasibility study with a US$500.3 million post-tax NPV and a target to produce by the end of 2028. The economics are substantial, but the funding package is not secured and nearly one-third of the mine plan relies on Inferred Resources.
Maxwell Dee
Maxwell Dee
16 Oct 2026
Redox enters FY27 from a position of record revenue, higher margins and a debt-free balance sheet, while its North American business passes $100 million in sales. The chemical distributor also reported 9% higher average selling prices in the first quarter, although volumes remained broadly flat and freight costs increased.
Victor Sage
Victor Sage
7 Oct 2026
Optiscan Imaging has lodged a 510(k) submission for its InForm digital pathology device, moving the product from development into formal US regulatory assessment. FDA clearance is not assured, but a successful determination could open the door to commercial distribution in the company’s target market.
Victor Sage
Victor Sage
1 Oct 2026
Atomic Eagle has formally executed the Mining Convention for its Madaouela uranium project in Niger, securing the legal, fiscal and operational framework for the asset. The agreement also triggers steps to end historical arbitration proceedings, while a US$5 million payment and a targeted JORC resource update now sit ahead of the company.
Maxwell Dee
Maxwell Dee
24 Sept 2026

Browse the archive

Full archive